| scholarly article | Q13442814 |
| P356 | DOI | 10.1373/CLINCHEM.2007.102046 |
| P698 | PubMed publication ID | 18375480 |
| P2093 | author name string | Florian Kronenberg | |
| Barbara Kollerits | |||
| Gustav Fraedrich | |||
| Mirjam Schnapka-Köpf | |||
| Barbara Rantner | |||
| Peter Klein-Weigel | |||
| Markus Haak | |||
| Ingrid Gruber | |||
| Anke Gehringer | |||
| Marietta Anderwald-Stadler | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | intermittent claudication | Q1097957 |
| claudication | Q2888709 | ||
| P304 | page(s) | 851-857 | |
| P577 | publication date | 2008-03-28 | |
| P1433 | published in | Clinical Chemistry | Q849687 |
| P1476 | title | Association between the UGT1A1 TA-repeat polymorphism and bilirubin concentration in patients with intermittent claudication: results from the CAVASIC study | |
| P478 | volume | 54 |
| Q34256214 | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia |
| Q37414494 | AC and AG dinucleotide repeats in the PAX6 P1 promoter are associated with high myopia. |
| Q35813137 | Bile pigments in pulmonary and vascular disease |
| Q28071435 | Bilirubin in coronary artery disease: Cytotoxic or protective? |
| Q37364279 | Conditional linkage and genome-wide association studies identify UGT1A1 as a major gene for anti-atherogenic serum bilirubin levels--the Framingham Heart Study. |
| Q34614162 | Genetic influences on serum bilirubin in American Indians: The Strong Heart Family Study |
| Q28295988 | Hyperbilirubinemia syndromes (Gilbert-Meulengracht, Crigler-Najjar, Dubin-Johnson, and Rotor syndrome) |
| Q40771927 | Influence of DNA extraction methods on relative telomere length measurements and its impact on epidemiological studies |
| Q33784377 | Lipoprotein (a) concentrations, apolipoprotein (a) phenotypes, and peripheral arterial disease in three independent cohorts |
| Q89617250 | Mitochondrial DNA copy number is associated with all-cause mortality and cardiovascular events in patients with peripheral arterial disease |
| Q57500367 | Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study |
| Q37778668 | Serum Bilirubin and Genes Controlling Bilirubin Concentrations as Biomarkers for Cardiovascular Disease |
| Q37111590 | Serum bilirubin levels, UGT1A1 polymorphisms and risk for coronary artery disease |
| Q34857822 | Serum bilirubin links UGT1A1*28 polymorphism and predicts long-term cardiovascular events and mortality in chronic hemodialysis patients |
| Q21559550 | The effect of UGT1A1 promoter polymorphism in the development of hyperbilirubinemia and cholelithiasis in hemoglobinopathy patients |
| Q37735239 | The fate of patients with intermittent claudication in the 21st century revisited - results from the CAVASIC Study |
Search more.